<

VALNEVA (EPA:VLA) Pfizer and Valneva Initiate Phase 3 Study of Lyme Disease Vaccine Candidate VLA15

Transparency directive : regulatory news

08/08/2022 22:45



Other stories

24/04/2024 05:08
24/04/2024 10:37
24/04/2024 03:26
24/04/2024 03:51
24/04/2024 05:00
24/04/2024 08:30
23/04/2024 20:01
23/04/2024 22:48
24/04/2024 07:14
23/04/2024 23:42
23/04/2024 17:12
24/04/2024 08:58
24/04/2024 03:01
23/04/2024 23:38
24/04/2024 08:27
24/04/2024 10:36
23/04/2024 13:53
24/04/2024 08:29
24/04/2024 07:12
23/04/2024 18:19
23/04/2024 06:14
23/04/2024 19:32
24/04/2024 07:42
24/04/2024 02:28
24/04/2024 01:11
24/04/2024 07:00
24/04/2024 08:18
24/04/2024 10:02
24/04/2024 09:52
24/04/2024 04:00
24/04/2024 08:05
24/04/2024 01:01
22/04/2024 18:16
22/04/2024 21:46
24/04/2024 03:26
24/04/2024 00:00
23/04/2024 14:15
24/04/2024 01:01